List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #20,901 to #20,950.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Ezetimibe overdosage → Ezetimibe
  2. Ezetimibe patient counseling information → Ezetimibe
  3. Ezetimibe use in specific populations → Ezetimibe
  4. Ezetimibe warnings and precautions → Ezetimibe
  5. Ezide → Hydrochlorothiazide
  6. F-actin → Actin
  7. F-center → F-Center
  8. F.A. Davis Company → F. A. Davis Company
  9. F.I.R.E. → Efficacy Of Fx06 In The Prevention Of Myocardial Reperfusion Injury Trial
  10. F.I.R.E. Study Misses Primary Endpoint → Special:Badtitle/NS100:F.I.R.E. Study Misses Primary Endpoint
  11. F.W. Aston → Francis William Aston
  12. F. necrophorum → Fusobacterium necrophorum
  13. F2R → Coagulation factor II receptor
  14. F508del → ΔF508
  15. F508del-CFTR → ΔF508
  16. FA → Fanconi anemia
  17. FAAH → Fatty acid amide hydrolase
  18. FAAT → Fatty Acid Antiarrhythmia Trial
  19. FACIT → Folate After Coronary Intervention Trial
  20. FACS → Fellow of the American College of Surgeons
  21. FACSM → Fellow of the American College of Sports Medicine
  22. FACT → Effect Of Nadroparin, A Low-Molecular-Weight Heparin, On Clinical And Angiographic Restenosis After Coronary Balloon Angioplasty
  23. FAC regimen → CAF regimen
  24. FADH → Flavin
  25. FAH gene → Fumarylacetoacetate hydrolase
  26. FALS → Amyotrophic lateral sclerosis
  27. FAMIS → Fosinopril In Acute Myocardial Infarction Study
  28. FANCC gene → Fanconi anemia, complementation group C
  29. FANCG gene → FANCG
  30. FANTASTIC → Randomized Multicenter Comparison Of Conventional Anticoagulation Versus Antiplatelet Therapy In Unplanned And Elective Coronary Stenting
  31. FAO → Food and Agriculture Organization
  32. FAST → Femoral Artery Stenting Trial
  33. FAST-MAG → Field Administration Of Stroke Therapy - Magnesium
  34. FASTER → Fibrinolytic And Aggrastat St Elevation Resolution First Abarelix Depot Study For Treating Endometriosis RapidlyFirst And Second Trimester Evaluation Of Risk
  35. FAS ligand → Fas ligand
  36. FATS → Familial Atherosclerosis Treatment Study (FATS)
  37. FATS Trial → Familial Atherosclerosis Treatment Study (FATS)
  38. FATS trial → Familial Atherosclerosis Treatment Study (FATS)
  39. FAVA → Provisionally unclassified vascular anomalies#Fibro adipose vascular anomaly (FAVA)
  40. FBG → Blood sugar
  41. FBS → Blood sugar
  42. FCM-R regimen → FMC-R regimen
  43. FCMR Regimen → FMC-R regimen
  44. FCM regimen → FMC regimen
  45. FD&C → Federal Food, Drug, and Cosmetic Act
  46. FDA → Food and Drug Administration
  47. FDA Advisors Under Review for the Potential of Financial Conflict. August 8, 2007 → Special:Badtitle/NS100:FDA Advisors Under Review for the Potential of Financial Conflict
  48. FDA Panel Recommends Approval of New DES → Special:Badtitle/NS100:FDA Panel Recommends Approval of New DES
  49. FDA Panel Review of Ticagrelor on July 28th, 2010 → FDA panel review of ticagrelor on July 28th, 2010
  50. FDA Requires Stronger Heart Failure Warning for Avandia and Actos → Special:Badtitle/NS100:FDA Requires Stronger Heart Failure Warning for Avandia and Actos

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"